精品日韩高清导航,日韩久久天堂一本,日韩欧免费一区二区三区,加勒比日韩线上AV

企業(yè)簡(jiǎn)介

無(wú)錫福祈制藥有限公司中日韩av电影,前身為無(wú)錫市第二制藥廠人人干人人操人人上,為江蘇省高新技術(shù)企業(yè)和江蘇省科技創(chuàng)新型企業(yè), 始建于1943年,位于風(fēng)景秀美的太湖之濱国产精品91在线播放。公司注冊(cè)資本32000萬(wàn)元人民幣性行为黄色网站,占地面積100,000平方米。公司主要生產(chǎn)抗生素原料藥久久综合无码一区丝袜、化學(xué)合成原料藥以及口服固體制劑国产美女高清自慰网站嫩草;發(fā)酵總量近500立方米亚洲无码在线天堂,建有8個(gè)符合國(guó)內(nèi)國(guó)際GMP要求的生產(chǎn)車間。

無(wú)錫福祈制藥有限公司秉承“祈康厚生欧美人在线,福澤民眾”的信念宗旨欧美大片性网址,致力于原料藥和成品藥研發(fā)和生產(chǎn),為客戶提供更好的產(chǎn)品與服務(wù)日韩插逼视频免费看。公司質(zhì)量管理體系完善色哟哟国产精品网站在线观看,設(shè)備儀器先進(jìn),產(chǎn)品質(zhì)量?jī)?yōu)良天天日狠狠插,配套設(shè)施完善a片无码在线观看网址。公司通過(guò)了由國(guó)內(nèi)外藥品監(jiān)督管理機(jī)關(guān)組織中囯GMP(2010)及歐洲GMP認(rèn)證,通過(guò)了清潔生產(chǎn)審核以及中經(jīng)科環(huán)基于GB/T24001-2016 idt ISO14001:2015 標(biāo)準(zhǔn)的環(huán)境管理體系認(rèn)證一区二区精品视频在线观看;GB/T45001-2020 idt ISO45001:2018 標(biāo)準(zhǔn)的職業(yè)健康安全管理體系認(rèn)證亚洲中文字幕性爱视频。

公司擁有一大批高技術(shù)專業(yè)人士組成的人才隊(duì)伍,從事著管理先锋生活资源、科研看免费老太婆一级毛片、開(kāi)發(fā)、生產(chǎn)特级毛片无码无遮挡免费播放、營(yíng)銷工作欧美一级特黄A片免费看是日本牲。

企業(yè)目前主要產(chǎn)品有硫酸奈替米星,硫酸西索米星亚洲国产精品九九九九婷婷,硫酸核糖霉素及螺旋霉素等抗生素藥物黄色视频搞得啊啊啊叫,嗎替麥考酚酯,他克莫司等器官移植抗排斥方面的藥物嗯好深啊用力哦嗯水好多视频,產(chǎn)品遠(yuǎn)銷歐洲国产无码Av动漫在线观看,美洲,非洲男女猛烈无遮挡午夜视频,及東南亞等幾十個(gè)國(guó)家和地區(qū)99riav国产原创国产精品。得天獨(dú)厚的先天優(yōu)勢(shì),造就了企業(yè)深厚的文化底蘊(yùn)网站A级;雄厚的科學(xué)技術(shù)力量久久免费经典黄色视频,為企業(yè)的長(zhǎng)足發(fā)展創(chuàng)造了機(jī)遇。在以質(zhì)量求生存91POPNY地址,以創(chuàng)新謀發(fā)展的經(jīng)營(yíng)理念的指導(dǎo)下在线日韩片精品免费观看,無(wú)錫福祈積極開(kāi)發(fā)治療器官移植抗排斥藥,新型抗腫瘤藥以及保肝藥等一系列的新產(chǎn)品欧美黑人黄色大片,并逐漸穩(wěn)步拓展成品藥市場(chǎng)WWW,色色色色色色色,,為企業(yè)中長(zhǎng)期的發(fā)展提供持久動(dòng)力。

強(qiáng)大的研發(fā)實(shí)力,堅(jiān)實(shí)的生產(chǎn)技術(shù)精品精品国产日韩26u,先進(jìn)的管理理念国产亚洲午夜福利专区,創(chuàng)新的經(jīng)營(yíng)思路和不斷自我提升的質(zhì)量管理體系是無(wú)錫福祈的競(jìng)爭(zhēng)優(yōu)勢(shì),企業(yè)正努力把自身建設(shè)成為國(guó)內(nèi)外知名的現(xiàn)代化制藥企業(yè)操女人的屄的网站。

 

WuxiFortune Pharmaceutical co., LTD is formerly known as Wuxi No. 2 Pharmaceutical Factory, is an new high-tech enterprise and technological innovation-based enterprise in Jiangsu Province. It was established in 1943 and located nearby the beautiful Taihu Lake. The registered capital is 320,000,000 RMB, and the total area is 100,000 m2. The main products are antibiotic APIs, chemical synthesis APIs and oral solid preparations. The total fermentation amount is about 500m3. There are eight workshops complied with the requirements of Current Chinese GMP (2010 version), which is equal to that of EU GMP, WHO GMP and ICH Q7A.

 

Wuxi Fortune pharmaceutical Co., LTD., adheres to the belief of "pray for the health, improve the living condition, bless the people", devotes to developing and manufacturing API and finished products, and provide better products and services. We have complete quality assurance system, advanced facility, providing good products, and perfect matching facilities. The company has passed the Chinese GMP (2010) Certification and European GMP Certification conducted by domestic and foreign regulatory administration authorities, cleaning production audit, the Environmental Management System Certification (GB/T24001-2016/ISO ISO14001:2015), and the Occupational Health and Safety Management System Certification (GB/T45001-2020/ISO 45001:2018) conducted by Beijing Zhongjing Quality Certification Co., Ltd.

 

At present, the main products are antibiotics drugs such as Netilmicin Sulfate, Sisomicin Sulfate, Ribostamycin Sulfate, and Spiramycin etc. and immunosuppressant like Mycophenolate Mofetiland Tacrolimus. Most of our products are exported to Europe, America, Africa, and Southeast Asia.

 

The advantagedsuperiority creates deep enterprise culture and the abundant science and technology strength create the development opportunities. Now Wuxi Fortune develops on the organ transplantation anti-rejection drugs, new antineoplastic and hepatoprotective. We also gradually expand the market of finished drug products to provide enduring power for the enterprise development. Strong research and development strength, firm production technology, advanced management ideas, innovative business ideas and continuous self-improvement quality management system are our competitive advantage. We work hard to make the enterprise become a famous modern pharmaceutical enterprise.